examples of glp-1 receptor agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Frontiers | GLP-1 Receptor Agonists:

Preserving Healthy Muscle during Weight Loss

Given that PCOS is frequently comorbid with steatotic liver disease and hypertriglyceridemia, we recommend intensified screening for gallbladder symptoms (e.g., right upper quadrant pain, fatty food intolerance) and regular monitoring of hepatobiliary markers during phases of rapid weight loss

cmh-2022-0330-Supplementary-3.pdf Supplementary Material 4

Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021